血友病A・血友病Bの組換え因子補充療法:世界の薬剤市場予測・分析...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Hemophilia A and B Recombinant Factor Replacement Therapy - Global Drug Forecast and Market Analysis to 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 16
1.2 List of Figures 21
2 Introduction 23
2.1 Catalyst 23
2.2 Related Reports 24
2.3 Upcoming Related Reports 24
3 Disease Overview 25
3.1 Etiology and Pathophysiology 25
3.1.1 Etiology 25
3.1.2 Pathophysiology 26
3.1.3 Prognosis and Quality of Life 28
3.2 Symptoms 29
3.2.1 Hemophilia A and B 29
3.2.2 Inhibitors 30
4 Epidemiology 31
4.1 Disease Background 31
4.2 Risk Factors and Comorbidities 32
4.3 Global Trends 33
4.4 Forecast Methodology 35
4.4.1 Sources Used 35
4.4.2 Sources Not Used 36
4.4.3 Forecast Assumptions and Methods 37
4.5 Epidemiological Forecast for Hemophilia A (2014-2024) 41
4.5.1 Diagnosed Prevalent Cases of Hemophilia A 41
4.5.2 Diagnosed Prevalent Cases of Hemophilia A by Age 42
4.5.3 Diagnosed Prevalent Cases of Hemophilia A by Sex 44
4.5.4 Age-Standardized Diagnosed Prevalence of Hemophilia A 46
4.6 Epidemiological Forecast for Hemophilia B (2014-2024) 47
4.6.1 Diagnosed Prevalent Cases of Hemophilia B 47
4.6.2 Diagnosed Prevalent Cases of Hemophilia B by Age 49
4.6.3 Diagnosed Prevalent Cases of Hemophilia B by Sex 51
4.6.4 Age-Standardized Diagnosed Prevalence of Hemophilia B 53
4.7 Epidemiological Forecast for Hemophilia A and Hemophilia B (2014-2024) 54
4.7.1 Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B 54
4.7.2 Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B by Sex 56
4.8 Discussion 58
4.8.1 Conclusions on Epidemiological Trends 58
4.8.2 Limitations of the Analysis 59
4.8.3 Strengths of the Analysis 60
5 Disease Management 61
5.1 Treatment Overview 61
5.1.1 Hemophilia A and B Diagnosis 61
5.1.2 Hemophilia A and B Treatment 62
5.1.3 Diagnosis of Inhibitors 64
5.1.4 Treatment of Inhibitors 65
5.2 US 67
5.2.1 Clinical Practice 67
5.3 France 69
5.3.1 Clinical Practice 69
5.4 Germany 71
5.4.1 Clinical Practice 71
5.5 Italy 73
5.5.1 Clinical Practice 73
5.6 Spain 75
5.6.1 Clinical Practice 75
5.7 UK 77
5.7.1 Clinical Practice 77
5.8 Japan 79
5.8.1 Clinical Practice 79
5.9 Argentina 81
5.9.1 Clinical Practice 81
6 Competitive Assessment 83
6.1 Overview 83
6.2 Strategic Competitive Assessment 83
6.3 Product Profiles – Hemophilia A 86
6.3.1 Advate (Octocog Alfa) 86
6.3.2 Kogenate FS/Helixate FS (Octocog Alfa) 92
6.3.3 Xyntha/ReFacto AF (Moroctocog Alfa) 99
6.3.4 Recombinate (Octocog Alfa) 103
6.3.5 Eloctate (Efmoroctocog Alfa) 107
6.3.6 NovoEight (Turoctocog Alfa) 113
6.3.7 Nuwiq (Simoctocog Alfa) 118
6.4 Product Profiles – Hemophilia B 123
6.4.1 BeneFIX (Nonacog Alfa) 123
6.4.2 Alprolix (Eftrenonacog Alfa) 128
6.4.3 Rixubis (Nonacog Gamma) 134
6.4.4 IXinity (Trenonacog Alfa) 138
6.5 Product Profiles – Hemophilia A and B with Inhibitors 143
6.5.1 NovoSeven RT (Eptacog Alfa) 143
7 Opportunity and Unmet Need 149
7.1 Overview 149
7.2 Opportunity Analysis 150
7.2.1 Longer-Lasting Recombinant Factors 150
7.2.2 Lower-Cost Recombinant Replacement Therapies 151
7.2.3 Lower Risk of Inhibitor Formation in Previously Untreated Patients 153
7.2.4 More Convenient Drug Administration 154
7.3 Unmet Needs Gap Analysis 154
7.3.1 Long-Acting FVIII Replacement Therapies 154
7.3.2 Gene Therapy Treatments for Hemophilia A and B 155
8 Pipeline Assessment 157
8.1 Overview 157
8.2 Late-Stage Development Candidates – Hemophilia A 158
8.2.1 Kovaltry (Octocog Alfa; BAY 81-8973) 159
8.2.2 Adynovate (BAX-855) 164
8.2.3 BAY 94-9027 (Damoctocog Alfa Pegol) 169
8.2.4 N8-GP (Turoctocog Alfa Pegol) 175
8.2.5 CSL-627 (rFVIII-SC) 181
8.2.6 GreenGene F (Beroctocog Alfa; GC1101C) 186
8.3 Late-Stage Development Candidates – Hemophilia B 192
8.3.1 CSL-654 (rIX-FP; Albutrepenonacog Alfa) 193
8.3.2 N9-GP (NN-7999; Nonacog Beta Pegol) 197
8.4 Late-Stage Development Candidates – Hemophilia A and B Bypassing Agents (Patients with Inhibitors) 203
8.4.1 BAX-817 (rFVIIa BI) 204
8.4.2 LR-769 (rhFVIIa) 209
8.4.3 CSL-689 (rVIIa-FP) 215
8.5 Promising Drugs in Early-Stage Development 220
8.5.1 Alternative Coagulation Promoters 220
8.5.2 Gene Therapies 223
9 Current and Future Players 227
9.1 Overview 227
9.2 Trends in Corporate Strategy 229
9.3 Company Profiles 229
9.3.1 Baxalta 229
9.3.2 Bayer 233
9.3.3 Biogen 235
9.3.4 CSL Behring 237
9.3.5 Novo Nordisk 239
9.3.6 Pfizer 242
10 Market Outlook 244
10.1 Global Markets 244
10.1.1 Forecast 244
10.1.2 Drivers and Barriers – Global Market 247
10.2 US 250
10.2.1 Forecast 250
10.2.2 Key Events 254
10.2.3 Drivers and Barriers 254
10.3 5EU 255
10.3.1 Forecast 255
10.3.2 Key Events 259
10.3.3 Drivers and Barriers – France 260
10.3.4 Drivers and Barriers – Germany 262
10.3.5 Drivers and Barriers – Italy 263
10.3.6 Drivers and Barriers – Spain 264
10.3.7 Drivers and Barriers – UK 265
10.4 Japan 266
10.4.1 Forecast 266
10.4.2 Key Events 270
10.4.3 Drivers and Barriers 270
10.5 Argentina 272
10.5.1 Forecast 272
10.5.2 Key Events 277
10.5.3 Drivers and Barriers 277
11 Appendix 279
11.1 Bibliography 279
11.2 Abbreviations 306
11.3 Methodology 309
11.4 Forecasting Methodology 309
11.4.1 Diagnosed Hemophilia Patients 309
11.4.2 Percent Drug-Treated Patients 310
11.4.3 Drugs Included in Each Therapeutic Class 310
11.4.4 Launch Dates 311
11.4.5 General Pricing Assumptions 312
11.4.6 Individual Drug Assumptions 313
11.4.7 Pricing of Pipeline Agents 322
11.5 Primary Research – KOLs Interviewed for this Report 323
11.6 Primary Research – Prescriber Survey 327
11.7 Real-World Data 327
11.8 About the Authors 329
11.8.1 Analyst 329
11.8.2 Therapy Area Director 329
11.8.3 Epidemiologists 329
11.8.4 Global Head of Healthcare 331
11.9 About GlobalData 332
11.10 Disclaimer 332


【レポート販売概要】

■ タイトル:血友病A・血友病Bの組換え因子補充療法:世界の薬剤市場予測・分析
■ 英文:PharmaPoint: Hemophilia A and B Recombinant Factor Replacement Therapy - Global Drug Forecast and Market Analysis to 2024
■ 発行日:2015年12月
■ 調査会社:GlobalData
■ 商品コード:GDHC116PIDR
■ 調査対象地域:グローバル
  • ナノパターニングの世界市場2017-2021
    About Nanopatterning Nanopatterning is concerned with imprinting nanoscale patterns on the substrate without using light or radiation-based techniques. Nanopatterning involves patterning on a nanometer scale and is currently a vital ingredient of nanotechnology. Nanopatterning and nanofabrication are essential when patterns with different densities are required for nanoscale devices. The primary b …
  • Bradycardia:グローバル臨床試験レビューH1, 2013
    Bradycardia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Bradycardia Global Clinical Trials Review, H1, 2013" provides data on the Bradycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bradycardia. It includes an overview of the trial numbers and their recruitment status as per the site of …
  • 電動無人航空機(E-UAV)の世界市場2019-2023
    About this market The growing realization of the UAV deployment in military operations has also encouraged vendors to offer UAVs that can be used in numerous commercial applications. These UAVs are also getting acceptances in other applications. including Internet provision in remote places. aerial photography and video recording. survey and document wildlife. and public service missions. Drones a …
  • 世界によける個人顧客用NAS(ネットワークアタッチトストレージ)市場動向(2014-2018)
    About Consumer NAS A network-attached storage (NAS) device, also termed a network-connected storage device, has its own IP address and can be accessed by multiple clients over a network. It consists of multiple hard disks arranged in a logical fashion to form a RAID structure. A consumer NAS system is centralized and offers multifunctional storage for the home network. It is useful for connecting …
  • チーズ成分の世界市場:ナチュラルチーズ、プロセスチーズ
    The global cheese ingredients market is projected to grow at a CAGR of 2.9% from 2015, to reach a projected value of USD 93.34 Billion by 2020. The market growth is driven by the increasing demand for cheese due to rapid growth in the fast food industry. The market is further driven by factors such as changing dietary patterns owing to changing lifestyle of people, increased disposable income and …
  • エレベータ及びエスカレータの世界市場2015-2019
    About elevators and escalators Elevators and escalators are positioned in buildings for efficient movement of people and goods within a building's premises. Elevators and escalators are installed in commercial buildings, residential buildings, mixed-used buildings, IT parks, hotels, restaurants, and retail outlets among others. They are also installed in public places to improve vehicle parking ma …
  • アグリビジネス(農業関連産業)の世界市場:穀物、油料種子、乳製品、家畜
    About Agribusiness Nanotechnology applications in global agribusiness are considered the new industrial revolution, and both developed and developing countries are investing in this technology to secure a sizeable market share. For instance, the US leads the world with an investment of $3.7 billion through its National Nanotechnology Initiative (NNI). The US is followed by Japan and the European U …
  • Familial Chylomicronemia (Type I Hyperlipoproteinemia):治療薬のグローバル治験動向(2014年上半期)
    Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014" provides data on the Familial Chylomicronemia (Type I Hyperlipoproteinemia) clinical trial scenario. This report provides elemental information and data relating to …
  • 世界のITアウトソーシング市場:ITアプリケーション/ITインフラアウトソーシング
    About IT Outsourcing IT outsourcing is the process of subcontracting the IT functions of an organization to a third-party vendor that has expertise in the required domains. IT outsourcing can be used as an effective strategy to build a high-performance IT organization. It helps client firms to increase their operational efficiency, concentrate on their core competencies, reduce time-to-market, obt …
  • 世界の天然脂肪酸市場2015
    The Global Natural Fatty Acids Industry Report 2015 is a professional and in-depth study on the current state of the Natural Fatty Acids industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Natural Fatty Acids market analysis is provided for the international markets including development trends, compet …
  • 世界の水晶発振器市場2015
    The Global Crystal Oscillator Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Crystal Oscillator industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Crystal Oscillator market analysis is provided for the international markets including development t …
  • 教室用ウェアラブル技術の世界市場2016-2020
    About the Classroom Wearables Technology Market The wearable technology has changed the way we communicate, collect, and analyze data. The wearable devices have similar mechanisms like smartphones and tablets and come in various shapes and sizes. These devices can be mounted anywhere on the body of the user depending on the requirement. Users can easily synchronize their smart wearable devices wit …
  • Royal Dutch Shell plc:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    Royal Dutch Shell plc Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Royal Dutch Shell plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
  • ブラジルの化粧品市場2015-2019
    Technavios research analyst predicts the cosmetics market in Brazil to grow at a CAGR of 11% during the forecast period. The increase in the number of working women is the primary driver for the growth of this market. The need to look fresh and presentable at the workplace is the key reason for the increase in expenditure on cosmetics by working women. Moreover, women in Brazil are now more inform …
  • 世界のマクロセル・モバイルバックホール 装置市場動向(2012-2016)
    TechNavio's analysts forecast the Global Macrocell Mobile Backhaul Equipment market to grow at a CAGR of 6.45 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in data traffic. The Global Macrocell Mobile Backhaul Equipment market has also been witnessing the growing adoption of IP/Ethernet technology. However, the reduced profits could po …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。